title: FDA notifications.  Ongoing safety review of abacavir, possible MI risk.
mesh_terms: D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D000099227:Abacavir
chemical_list: D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir